:

Which patient should not be prescribed alendronate Fosamax for osteoporosis?

According to the Bone Health and Osteoporosis Foundation, approximately 10 million Americans have osteoporosis, and another 44 million have low bone mass. While alendronate (Fosamax) is a common treatment, certain patient profiles pose serious contraindications, raising the critical question: which patient should not be prescribed alendronate Fosamax for osteoporosis?